<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Topical Dermatologic Corticosteroids: In Vivo Bioequivalence; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Topical Dermatologic Corticosteroids: In Vivo Bioequivalence; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2022-10-24 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Topical Dermatologic Corticosteroids: In Vivo Bioequivalence." This draft guidance is intended to assist applicants who submit abbreviated new drug applications (ANDAs) for topical dermatologic corticosteroid products of all potency groups (referred to in this notice as topical corticosteroids). The draft guidance describes recommendations for an in vivo pharmacodynamic appr...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-23032</p>
    <p><strong>Publication Date:</strong> 2022-10-24</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/10/24/2022-23032/topical-dermatologic-corticosteroids-in-vivo-bioequivalence-draft-guidance-for-industry-availability">https://www.federalregister.gov/documents/2022/10/24/2022-23032/topical-dermatologic-corticosteroids-in-vivo-bioequivalence-draft-guidance-for-industry-availability</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-23032</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
